UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study

HIV medicine, 2011-08, Vol.12 (7), p.412-421

2011

Volltextzugriff (PDF)

Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)

Scandinavian journal of rheumatology, 2017-11, Vol.46 (6), p.446-453

2017

Volltextzugriff (PDF)

Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

The Journal of infectious diseases, 2004-03, Vol.189 (6), p.1056-1074

2004

Volltextzugriff (PDF)

The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study

HIV medicine, 2006-05, Vol.7 (4), p.218-230

2006

Volltextzugriff (PDF)

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV‐1‐infected patients treated with abacavir

HIV medicine, 2010-03, Vol.11 (3), p.200-208

2010

Volltextzugriff (PDF)

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

The Lancet (British edition), 2014-07, Vol.384 (9939), p.241-248

2014

Volltextzugriff (PDF)

Predictors of hypertension and changes of blood pressure in HIV-infected patients

Antiviral therapy, 2005-01, Vol.10 (7), p.811-823

2005

Volltextzugriff (PDF)

The Coding Causes of Death in HIV (CoDe) Project: Initial Results and Evaluation of Methodology

Epidemiology (Cambridge, Mass.), 2011-07, Vol.22 (4), p.516-523

2011

Volltextzugriff (PDF)

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16‐17 November 2016: a summary

HIV medicine, 2018-02, Vol.19 (2), p.77-80

2018

Volltextzugriff (PDF)

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

The Lancet (British edition), 2008-04, Vol.371 (9622), p.1417-1426

2008

Volltextzugriff (PDF)

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

AIDS (London), 2010-07, Vol.24 (11), p.1667-1678

2010

Volltextzugriff (PDF)

Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

HIV medicine, 2016-04, Vol.17 (4), p.255-268

2016

Volltextzugriff (PDF)

Serious fatal and nonfatal non-AIDS-defining illnesses in Europe

Journal of acquired immune deficiency syndromes (1999), 2010-10, Vol.55 (2), p.262

2010

Volltextzugriff (PDF)

Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

HIV medicine, 2003-01, Vol.4 (1), p.1-10

2003

Volltextzugriff (PDF)

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

The Journal of infectious diseases, 2016-10, Vol.214 (8), p.1212-1220

2016

Volltextzugriff (PDF)

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

Current HIV/AIDS reports, 2015-12, Vol.12 (4), p.375-387

2015

Volltextzugriff (PDF)

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

AIDS (London), 2008-10, Vol.22 (16), p.2143-2153

2008

Volltextzugriff (PDF)

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

Journal of acquired immune deficiency syndromes (1999), 2015-04, Vol.68 (5), p.568

2015

Volltextzugriff (PDF)

Increased risk of cardiovascular disease (CVD) with age in HIV‐positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

HIV medicine, 2014-11, Vol.15 (10), p.595-603

2014

Volltextzugriff (PDF)

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

AIDS (London), 2009-08, Vol.23 (13), p.1689-1699

2009

Volltextzugriff (PDF)

Dialysis and renal transplantation in HIV-infected patients: a European survey

Journal of acquired immune deficiency syndromes (1999), 2010-12, Vol.55 (5), p.582

2010

Volltextzugriff (PDF)

Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource-Limited Settings

The Journal of infectious diseases, 2009-09, Vol.200 (5), p.687-697

2009

Volltextzugriff (PDF)

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

Journal of antimicrobial chemotherapy, 2010-03, Vol.65 (3), p.548-555

2010

Volltextzugriff (PDF)

Cardio- and cerebrovascular events in HIV-infected persons

AIDS (London), 2004-09, Vol.18 (13), p.1811-1817

2004

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(93)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study

Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)

Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV‐1‐infected patients treated with abacavir

Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Predictors of hypertension and changes of blood pressure in HIV-infected patients

The Coding Causes of Death in HIV (CoDe) Project: Initial Results and Evaluation of Methodology

European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16‐17 November 2016: a summary

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

Serious fatal and nonfatal non-AIDS-defining illnesses in Europe

Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

Increased risk of cardiovascular disease (CVD) with age in HIV‐positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

Dialysis and renal transplantation in HIV-infected patients: a European survey

Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource-Limited Settings

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

Cardio- and cerebrovascular events in HIV-infected persons

Suchergebnisse filtern